Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05888506 · ClinicalTrials.gov registry record · NA

Ketone Ester Supplementation and Nocturnal Blood Pressure

A NA study, sponsored by Georgia Southern University.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT05888506 is a NA study that has completed, run by Georgia Southern University. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05888506, a NA study, has completed, sponsored by Georgia Southern University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

Cardiovascular disease (CVD) is the number one cause of death globally and high blood pressure (i.e., hypertension) is the leading modifiable risk factor for CVD and all-cause mortality. Advancing age is the primary risk factor for hypertension and CVD. Moreover, compared to younger adults, older adults exhibit reduced nocturnal dipping of blood pressure resulting in elevated nighttime blood pressure values, which are a better predictor of cardiovascular outcomes than daytime blood pressure. Intriguingly, recently published rodent data suggests that ketone supplementation protects against hypertension, blood vessel dysfunction, and kidney injury. Whether ketone supplementation provides vascular health benefits in humans remains to be determined. Therefore, the investigations seek to conduct an acute ketone supplementation study to determine whether ketone supplementation may restore a more healthy nighttime blood pressure phenotype in middle-aged and older adults. The investigations will also determine whether ketone supplementation influences nocturnal heart rate variability, a non-invasive of autonomic function that may be influenced by ketone supplementation in a manner that influences blood pressure.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Ketone Ester

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-08-01
Est. Completion 2023-10-03
Phase NA

Sponsor

Georgia Southern University

4 total trials

What the Registry Record Tells You About NCT05888506

The ClinicalTrials.gov registry entry for NCT05888506 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgia Southern University, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT05888506 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05888506 about?

NCT05888506 is a clinical study titled "Ketone Ester Supplementation and Nocturnal Blood Pressure". Cardiovascular disease (CVD) is the number one cause of death globally and high blood pressure (i.e., hypertension) is the leading modifiable risk factor for CVD and all-cause mortality. Advancing age is the primary risk factor for hypertension and CVD. Moreover, compared to younger adults, older ad...

What is the current status of trial NCT05888506?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-08-01. Estimated completion is 2023-10-03.

What interventions are being tested in trial NCT05888506?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Ketone Ester (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05888506?

This trial is sponsored by Georgia Southern University, which has 4 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.